Cost-Effectiveness and Economic Burden of PCI

Cardiovasc Revasc Med. 2018 Jul-Aug;19(5 Pt B):561-563. doi: 10.1016/j.carrev.2018.07.009.

Authors

Micaela Iantorno¹, William S Weintraub²

Affiliations

¹ Section of Interventional Cardiology, MedStar Heart & Vascular Institute, Georgetown University, Washington, DC.
² Section of Interventional Cardiology, MedStar Heart & Vascular Institute, Georgetown University, Washington, DC. Electronic address: William.s.weintraub@medstar.net.

PMID: 30146118
DOI: 10.1016/j.carrev.2018.07.009

No abstract available

Publication types

Editorial
Comment

MeSH terms

Coronary Artery Disease*
Cost of Illness
Cost-Benefit Analysis
Humans
Percutaneous Coronary Intervention*